Showing results (51-60 of 59) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
International Journal of Medical Informatics|July 20, 2023
A novel systematic pipeline for increased predictability and explainability of growth patterns in children using trajectory featuresParaskevi Massara, Lorena Lopez-Dominguez, Celine Bourdon, et al.Journal of the American College of Surgeons|July 30, 2025
Postoperative Pain Management in the US vs Low-and-Middle-Income Countries by US SurgeonsMatthew S Linz, Fatemeh P Parvin-Nejad, Nivetha Srinivasan, et al.Advances in Therapy|July 25, 2023
Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving ChemotherapyJerome Goldschmidt, Lowell Hart, Jeffrey Scott, et al.Proceedings of the National Academy of Sciences of the United States of America|September 25, 2023
Trehalose-6-phosphate signaling regulates lateral root formation in Arabidopsis thalianaStefania Morales-Herrera, Joris Jourquin, Frederic Coppé, et al.Scientific Reports|August 30, 2020
Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumabMaria Inmaculada Dominguez-Mozo, Silvia Perez-Perez, Luisa María Villar, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 6, 2022
Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic Metabolic Risk FactorsJuan Carlos Rodriguez-Duque, José Luis Calleja, Paula Iruzubieta, et al.Blood Advances|June 3, 2026
Daratumumab in Transplant-Ineligible or -Deferred Newly Diagnosed Multiple Myeloma: Minimal Residual Disease in CEPHEUSSonja Zweegman, Thierry Facon, Vania Hungria, et al.Nature Medicine|February 5, 2025
Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trialSaad Z Usmani, Thierry Facon, Vania Hungria, et al.Blood|August 19, 2024
Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS studyTeena Bhatla, Laura E Hogan, David T Teachey, et al.Pageof 6